836 DIFFERENCES IN VIROLOGIC RESPONSE PATTERNS BETWEEN HIV/HCV CO-INFECTED AND HCV MONO-INFECTED PATIENTS TREATED WITH PEGINTERFERON AND RIBAVIRIN WITH DOSE ADJUSTED TO BODY WEIGHT (1000–1200 MG/DAY) | Publicación